SEC Comment Letter 0000000000-23-009189 to Better Therapeutics, Inc. (CIK 0001832415)
Better Therapeutics, Inc. (CIK 0001832415)
Date: Aug. 22, 2023 · CIK: 0001832415 · Accession: 0000000000-23-009189
AI Filing Summary & Sentiment
File numbers found in text: 333-273861
Letter
United States securities and exchange commission logo August 22, 2023 Frank Karbe Chief Executive Officer Better Therapeutics, Inc. 548 Market Street #49404 San Francisco, California, 94104 Re:Better Therapeutics, Inc. Registration Statement on Form S-3 Filed August 10, 2023 File No. 333-273861 Dear Frank Karbe: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Shoaib Ghias, Esq.
Show Raw Text
United States securities and exchange commission logo
August 22, 2023
Frank Karbe
Chief Executive Officer
Better Therapeutics, Inc.
548 Market Street #49404
San Francisco, California, 94104
Re:Better Therapeutics, Inc.
Registration Statement on Form S-3
Filed August 10, 2023
File No. 333-273861
Dear Frank Karbe:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Shoaib Ghias, Esq.